Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation (Q45354632)
Jump to navigation
Jump to search
scientific article published in October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation |
scientific article published in October 2012 |
Statements
1 reference
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation (English)
1 reference
1 reference
1 reference
Regis Peffault de Latour
1 reference
Anna D Petropoulou
1 reference
Alienor Xhaard
1 reference
Daniel Weisdorf
1 reference
Patricia Ribaud
1 reference
Paula Rodriguez-Otero
1 reference
Félix Agbalika
1 reference
Alexis Talbot
1 reference
Hélène Moins-Teisserenc
1 reference
Maryvonnick Carmagnat
1 reference
Gerard Socié
1 reference
Marie Robin
1 reference
1 October 2012
1 reference
1 reference
94
1 reference
8
1 reference
879-883
1 reference
Identifiers
1 reference
1 reference